Abd Elhamid, M.A.; Mehanna, E.T.; Mesbah, N.M.; Abo-Elmatty, D.M.; Jamil, L.; Hafez, M.M.
Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats. Biomedicines 2026, 14, 642.
https://doi.org/10.3390/biomedicines14030642
AMA Style
Abd Elhamid MA, Mehanna ET, Mesbah NM, Abo-Elmatty DM, Jamil L, Hafez MM.
Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats. Biomedicines. 2026; 14(3):642.
https://doi.org/10.3390/biomedicines14030642
Chicago/Turabian Style
Abd Elhamid, Marwa A., Eman T. Mehanna, Noha M. Mesbah, Dina M. Abo-Elmatty, Lubna Jamil, and Mohamed M. Hafez.
2026. "Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats" Biomedicines 14, no. 3: 642.
https://doi.org/10.3390/biomedicines14030642
APA Style
Abd Elhamid, M. A., Mehanna, E. T., Mesbah, N. M., Abo-Elmatty, D. M., Jamil, L., & Hafez, M. M.
(2026). Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats. Biomedicines, 14(3), 642.
https://doi.org/10.3390/biomedicines14030642
